Why the study?
Does transcatheter heart valve deployment geometry affect the risk of leaflet thrombosis in patients undergoing TAVR?
Population
Patients with CoreValve, Evolut R, and SAPIEN 3 transcatheter aortic valve replacement enrolled in the…
Comparison
Transcatheter aortic valve replacement vs Patients without hypoattenuated leaflet thickening
Design
Cohort
Follow-up
postprocedural
Authors
Loading...
Leaflet thrombosis was associated with greater SAPIEN 3 expansion and deeper CoreValve implantation; leaves open whether optimized deployment reduces risk.
Does transcatheter heart valve deployment geometry affect the risk of leaflet thrombosis in patients undergoing TAVR?
Deployed transcatheter heart valve geometry, including expansion diameter and implant depth, may influence the risk of leaflet thrombosis, with supraannular deployment potentially reducing flow stasis.
Midha et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: